IMTHERAPEUTICS

imtherapeutics-logo

IM Therapeutics develops personalized immunotherapeutic drugs for autoimmune diseases based on the genetic risk attributed by human leukocyte antigen (HLA) genes. Their lead candidate drug is an oral drug that starves the autoimmune process in type 1 diabetes (T1D) by blocking DQ8 on specific immune cells. Their goal is to preserve pancreatic beta-cell function and maintain normal insulin production in at-risk and early-stage patients with type 1 diabetes. They are leveraging Their HLA platform to expand their pipeline beyond T1D, to include drug development for Celiac disease (gluten sensitivity) as well as potential additional autoimmune diseases. It was founded in 2015 and is headquartered in Aurora, Colorado.
#SimilarOrganizations #People #Financial #Website #More

IMTHERAPEUTICS

Social Links:

linkedin

Linkedin

twitter

Twitter

Industry:
Biotechnology Health Care Medical

Founded:
2015-01-01

Address:
Aurora, Colorado, United States

Country:
United States

Website Url:
http://www.imtherapeutics.com

Total Employee:
1+

Status:
Active

Contact:
781-235-3060

Email Addresses:
[email protected]

Total Funding:
10 M USD

Technology used in webpage:
Viewport Meta SPF SSL By Default Google Font API LetsEncrypt Content Delivery Network Google Apps For Business GoDaddy DNS YouTube COVID-19


Similar Organizations

entrada-therapeutics-logo

Entrada Therapeutics

Entrada Therapeutics is a developer of novel therapeutics intended to treat devastating diseases.

geneos-therapeutics-logo

Geneos Therapeutics

Geneos Therapeutics is a developer of a neo-antigen based personalized immunotherapy designed to offer cancer treatment.

tiburio-therapeutics-logo

Tiburio Therapeutics

Tiburio Therapeutics is a developer of drug compounds intended to treat tumors and endocrine diseases.


Current Advisors List

not_available_image

Sean Doherty Board Of Director @ IMTherapeutics
Board_member

jason-dinges_image

Jason Dinges Board Of Director @ IMTherapeutics
Board_member

Current Employees Featured

tom-shea_image

Tom Shea
Tom Shea CFO/COO @ IMTherapeutics
CFO/COO
2020-07-01

aaron-michels_image

Aaron Michels
Aaron Michels Co-founder & Chief Scientific Officer @ IMTherapeutics
Co-founder & Chief Scientific Officer

not_available_image

Peter Gottlieb
Peter Gottlieb CMO and Interim CEO @ IMTherapeutics
CMO and Interim CEO
2015-07-01

nandan-padukone_image

Nandan Padukone
Nandan Padukone CEO & Board Member @ IMTherapeutics
CEO & Board Member
2019-06-01

Founder


aaron-michels_image

Aaron Michels

not_available_image

Peter Gottlieb

Investors List

jdrf-t1d-fund_image

JDRF T1D Fund

JDRF T1D Fund investment in Series A - IMTherapeutics

morningside-technology-ventures_image

Morningside Venture Investments

Morningside Venture Investments investment in Series A - IMTherapeutics

Official Site Inspections

http://www.imtherapeutics.com Semrush global rank: 5.89 M Semrush visits lastest month: 1.4 K

  • Host name: 198.185.159.145
  • IP address: 198.185.159.145
  • Location: New York United States
  • Latitude: 40.7157
  • Longitude: -74
  • Metro Code: 501
  • Timezone: America/New_York
  • Postal: 10013

Loading ...

More informations about "IMTherapeutics" on Search Engine

dfkcompany.com © 2022. All rights reserved